Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients. Journal of Pharmaceutical and Sciences, v. 7, n. 4, p. 562–570, 31 Oct.2024.